Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer
Veterinary and Comparative Oncology · 2023
DOI: 10.1111/vco.12926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2023. Verfasst von Mohamed Issam Atmane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Département de Pathologie et de Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada. Hauptthemen laut MEDLINE: Mammary Glands, Human, Dog Diseases, Breast Neoplasms, Mammary Neoplasms, Animal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds du centenaire, Faculté de médecine vétérinaire, Université de Montréal, Canadian Foundation for Innovation, Fonds de Recherche du Québec.
Abstract (Originalsprache)
The Hippo signalling pathway is involved in breast cancer and canine mammary tumour (CMT). This study sought to evaluate the efficacy of fluvastatin on the Hippo pathway and its main effectors, YAP and TAZ, in vivo in a murine CMT cell line xenograft model. On treatment day 1, mice were divided into four groups: vehicle, fluvastatin, doxorubicin or a combination therapy. Tumour volumes were monitored with callipers and tissues harvested on day 28th of treatment. Histopathological examination of tumour tissues and major organs was performed as well as tumour evaluation of necrosis, apoptosis, cellular proliferation, expression of YAP, TAZ and the mRNA levels of four of their target genes ( CTGF, CYR61, ANKRD1 and RHAMM2 ). Results showed a statistically significant variation in tumour volumes only for the combination therapy and final tumour weight only for the doxorubicin group compared to control. There was no significant difference in tumour necrosis, expression of CC3, ki‐67, YAP and TAZ measured by immunohistochemistry and in the mRNA levels of the target genes. Unexpectedly, lung metastases were found in the control group (9) and not in the fluvastatin treated group (7). In addition, mass spectrometry‐based quantification of fluvastatin reveals concentrations comparable to levels reported to exert therapeutic effects. This study shows that fluvastatin tumours concentration reached therapeutic levels without having an effect on the hippo pathway or various tumour parameters. Interestingly, only the control group had lung metastases. This study is the first to explore the repurposing of statins for cancer treatment in veterinary medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Pathologie et de Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
- Département de Biomédecine Vétérinaire, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec, Canada.
- Centre de recherche sur le cerveau et l'apprentissage (CIRCA), Université de Montréal, Montréal, Québec, Canada.
- Centre de recherche en reproduction et fertilité (CRRF), Université de Montréal, Saint-Hyacinthe, Québec, Canada.
ORCID-Profile: Marilène Paquet
Förderung
- Fonds du centenaire, Faculté de médecine vétérinaire, Université de Montréal
- Canadian Foundation for Innovation
- Fonds de Recherche du Québec
- Government of Quebec
- Canada Research Chair in Metrology of Bioactive Molecule and Target Discovery
Zitieren
APA
Atmane, M. I., Vigneau, A. L., Beaudry, F., Rico, C., Boerboom, D., & Paquet, M. (2023). Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.12926
Vancouver
Atmane MI, Vigneau AL, Beaudry F, Rico C, Boerboom D, Paquet M. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer. Veterinary and Comparative Oncology. 2023. doi:10.1111/vco.12926
BibTeX
@article{Atmane2023,
author = {Atmane, Mohamed Issam and Vigneau, Anne-Laurence and Beaudry, Francis and Rico, Charlène and Boerboom, Derek and Paquet, Marilène},
title = {Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer},
journal = {Veterinary and Comparative Oncology},
year = {2023},
doi = {10.1111/vco.12926}
}
EUVIMED